Generic and innovative drugs market in CIS countries 2013 Russia Ukraine and Kazakhstan

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Russia: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

Russia: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • December 2014

The report provides an in-depth analysis of the Russian Market of Heterocyclic Compounds. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key ...

Industries: Drug and Medication | Countries: Russian Federation

Russia: Lactams From Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

Russia: Lactams From Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • December 2014

The report provides an in-depth analysis of the Russian Market of Lactams From Heterocyclic Compounds. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify ...

Industries: Drug and Medication | Countries: Russian Federation

Russia: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

Russia: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • December 2014

The report provides an in-depth analysis of the Russian Market of Hormones, Prostaglandins, Thromboxanes And Leukotrienes. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, ...

Industries: Drug and Medication | Countries: Russian Federation

Russia: Antibiotics - Market Report. Analysis and Forecast to 2020

Russia: Antibiotics - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • December 2014

The report provides an in-depth analysis of the Russian Market of Antibiotics. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key drivers and ...

Industries: Drug and Medication | Countries: Russian Federation

Russia: Vaccines For Human Medicine - Market Report. Analysis and Forecast to 2020

Russia: Vaccines For Human Medicine - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • December 2014

The report provides an in-depth analysis of the Russian Market of Vaccines For Human Medicine. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the ...

Industries: Drug and Medication | Countries: Russian Federation

Arterium Corporation (GFARM) - Financial and Strategic SWOT Analysis Review

Arterium Corporation (GFARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Arterium Corporation (Arterium) is a pharmaceutical company. The company develops, manufactures and markets pharmaceuticals, and antibacterial and herbal based medications. Its products include acelysin, acetylsalicylic acid, alteyca galychpharm, ambroxol, kanamycin, nicergolin, nifuroxazide, ...

Industries: Drug and Medication | Countries: Ukraine, Uzbekistan, Kazakhstan, Azerbaijan, Russian Federation, Belarus

Veropharm (VRPH) - Financial and Strategic SWOT Analysis Review

Veropharm (VRPH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Veropharm is a pharmaceutical company. The company develops and manufactures generic pharmaceutical drugs, oncological medications, and medical adhesive bandages. It operates through three plants, such as Voronezh Chemical-Pharmaceutical Plant, Belgorod and Basil plant, and Pokrov ready-made ...

Industries: Drug and Medication | Countries: Russian Federation

Genexine, Inc. (095700) - Financial and Strategic SWOT Analysis Review

Genexine, Inc. (095700) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Genexine, Inc. (Genexine) is a biotechnology company. The company develops and conducts research on therapeutic vaccines for incurable diseases and next-generation antibody fusion protein drugs such as super-biosimilars. Its products include GX-E2 for Anemia, GX-G6 for Diabetes, GX-H9 for Dwarfism, ...

Industries: Drug and Medication | Countries: Brazil, Russian Federation, Thailand, South Korea, India

CNS Drug News 17 NOVEMBER 2014

CNS Drug News 17 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 24 pages

Industry Trend Analysis - FDA Approval Will See Lemtrada Become A Blockbuster Industry Brief - Impax Submits MAA For IPX066 Industry Brief - NeuroDerm Reports Positive Top-Line Phase II Results In Moderate-To-Severe PD Industry Brief - Anavex Receives Regulatory Approval To Initiate Phase IIa Trial In ...

Industries: Drug and Medication | Countries: Australia, Luxembourg, United States, Russian Federation, Germany, Belgium

Russia Pharmaceuticals and Healthcare Report Q4 2104

Russia Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2014
  • 112 pages

Includes 3 FREE quarterly updates BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in the country. With the EU and the US applying further sanctions, the business environment in the country is deteriorating. As the government pushes through protectionist ...

Industries: Drug and Medication | Countries: Russian Federation

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.